Literature DB >> 21765214

Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway.

Shigeru Shibata1, ShengYu Mu, Hiroo Kawarazaki, Kazuhiko Muraoka, Ken-ichi Ishizawa, Shigetaka Yoshida, Wakako Kawarazaki, Maki Takeuchi, Nobuhiro Ayuzawa, Jun Miyoshi, Yoshimi Takai, Akira Ishikawa, Tatsuo Shimosawa, Katsuyuki Ando, Miki Nagase, Toshiro Fujita.   

Abstract

Hypertension is a leading contributor to cardiovascular mortality worldwide. Despite this, its underlying mechanism(s) and the role of excess salt in cardiorenal dysfunction are unclear. Previously, we have identified cross-talk between mineralocorticoid receptor (MR), a nuclear transcription factor regulated by the steroid aldosterone, and the small GTPase Rac1, which is implicated in proteinuric kidney disease. We here show that high-salt loading activates Rac1 in the kidneys in rodent models of salt-sensitive hypertension, leading to blood pressure elevation and renal injury via an MR-dependent pathway. We found that a high-salt diet caused renal Rac1 upregulation in salt-sensitive Dahl (Dahl-S) rats and downregulation in salt-insensitive Dahl (Dahl-R) rats. Despite a reduction of serum aldosterone levels, salt-loaded Dahl-S rats showed increased MR signaling in the kidneys, and Rac1 inhibition prevented hypertension and renal damage with MR repression. We further demonstrated in aldosterone-infused rats as well as adrenalectomized Dahl-S rats with aldosterone supplementation that salt-induced Rac1 and aldosterone acted interdependently to cause MR overactivity and hypertension. Finally, we confirmed the key role of Rac1 in modulating salt susceptibility in mice lacking Rho GDP-dissociation inhibitor α. Therefore, our data identify Rac1 as a determinant of salt sensitivity and provide insights into the mechanism of salt-induced hypertension and kidney injury.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21765214      PMCID: PMC3148723          DOI: 10.1172/JCI43124

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  62 in total

1.  Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research.

Authors:  Theodore W Kurtz; Karen A Griffin; Anil K Bidani; Robin L Davisson; John E Hall
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

2.  Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system.

Authors:  Steven D Crowley; Susan B Gurley; Michael I Oliverio; A Kathy Pazmino; Robert Griffiths; Patrick J Flannery; Robert F Spurney; Hyung-Suk Kim; Oliver Smithies; Thu H Le; Thomas M Coffman
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

3.  Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization.

Authors:  Jose A Cancelas; Andrew W Lee; Rethinasamy Prabhakar; Keith F Stringer; Yi Zheng; David A Williams
Journal:  Nat Med       Date:  2005-07-17       Impact factor: 53.440

4.  Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.

Authors:  Iris Z Jaffe; Michael E Mendelsohn
Journal:  Circ Res       Date:  2005-02-17       Impact factor: 17.367

5.  Modulation of human mineralocorticoid receptor function by protein kinase A.

Authors:  C Massaad; N Houard; M Lombès; R Barouki
Journal:  Mol Endocrinol       Date:  1999-01

6.  Construction of a double congenic strain to prove an epistatic interaction on blood pressure between rat chromosomes 2 and 10.

Authors:  J P Rapp; M R Garrett; A Y Deng
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

7.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

8.  Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha.

Authors:  A Togawa; J Miyoshi; H Ishizaki; M Tanaka; A Takakura; H Nishioka; H Yoshida; T Doi; A Mizoguchi; N Matsuura; Y Niho; Y Nishimune; S i Nishikawa; Y Takai
Journal:  Oncogene       Date:  1999-09-23       Impact factor: 9.867

9.  Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A.

Authors:  Yoshio Terada; Takahiko Kobayashi; Hitoshi Kuwana; Hiroyuki Tanaka; Seiji Inoshita; Michio Kuwahara; Sei Sasaki
Journal:  J Am Soc Nephrol       Date:  2005-06-23       Impact factor: 10.121

10.  Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.

Authors:  C G Brilla; K T Weber
Journal:  J Lab Clin Med       Date:  1992-12
View more
  83 in total

1.  Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.

Authors:  Alessia Buglioni; Valentina Cannone; Alessandro Cataliotti; S Jeson Sangaralingham; Denise M Heublein; Christopher G Scott; Kent R Bailey; Richard J Rodeheffer; Paolo Dessì-Fulgheri; Riccardo Sarzani; John C Burnett
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Salt causes aging-associated hypertension via vascular Wnt5a under Klotho deficiency.

Authors:  Wakako Kawarazaki; Risuke Mizuno; Mitsuhiro Nishimoto; Nobuhiro Ayuzawa; Daigoro Hirohama; Kohei Ueda; Fumiko Kawakami-Mori; Shigeyoshi Oba; Takeshi Marumo; Toshiro Fujita
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

3.  Renin knockout rat: control of adrenal aldosterone and corticosterone synthesis in vitro and adrenal gene expression.

Authors:  Hershel Raff; Ashley Gehrand; Eric D Bruder; Matthew J Hoffman; William C Engeland; Carol Moreno
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-11-12       Impact factor: 3.619

Review 4.  Context-dependent mechanisms modulating aldosterone signaling in the kidney.

Authors:  Shigeru Shibata
Journal:  Clin Exp Nephrol       Date:  2016-02-05       Impact factor: 2.801

5.  Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1.

Authors:  Jonatan Barrera-Chimal; Gwennan André-Grégoire; Aurelie Nguyen Dinh Cat; Sebastian M Lechner; Jérôme Cau; Sonia Prince; Peter Kolkhof; Gervaise Loirand; Vincent Sauzeau; Thierry Hauet; Frédéric Jaisser
Journal:  J Am Soc Nephrol       Date:  2017-01-13       Impact factor: 10.121

Review 6.  Aldosterone in heart disease.

Authors:  Anastasia S Mihailidou
Journal:  Curr Hypertens Rep       Date:  2012-04       Impact factor: 5.369

Review 7.  A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension.

Authors:  J B Byrd; R D Brook
Journal:  J Hum Hypertens       Date:  2013-05-23       Impact factor: 3.012

Review 8.  Sodium retention and volume expansion in nephrotic syndrome: implications for hypertension.

Authors:  Evan C Ray; Helbert Rondon-Berrios; Cary R Boyd; Thomas R Kleyman
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 9.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

Review 10.  The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.

Authors:  Atsuhisa Sato
Journal:  Hypertens Res       Date:  2015-03-12       Impact factor: 3.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.